Globus Medical (GMED) Convertible Debt (2023)
Globus Medical's (GMED) quarterly Convertible Debt came in at $417.4 million in Q4 2023, up 1.87% on a QoQ basis from $409.7 million in Q3 2023.
Globus Medical (GMED) Convertible Debt (2023) Analysis & Trends
Globus Medical (GMED) has 1 years of Convertible Debt data on file, last reported at $417.4 million in Q4 2023.
- Quarterly Convertible Debt changed N/A year-over-year to $417.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $417.4 million (changed N/A YoY) and the FY2023 annual result came in at $417.4 million, changed N/A from the prior year.
- Convertible Debt climbed to $417.4 million in Q4 2023, from $409.7 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $417.4 million in Q4 2023 to a low of $409.7 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Globus Medical | 11.59 Bn | 11.00 Bn | 548.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 417.40 Mn |
| Sep 30, 2023 | 409.72 Mn |